Avalo Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.

About AVTX

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. 

CEO
Garry Arthur Neil
CEOGarry Arthur Neil
Employees
23
Employees23
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2011
Founded2011
Employees
23
Employees23

AVTX Key Statistics

Market cap
52.03M
Market cap52.03M
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
—
Dividend yield—
Average volume
79.73K
Average volume79.73K
High today
$5.08
High today$5.08
Low today
$4.77
Low today$4.77
Open price
$5.08
Open price$5.08
Volume
38.24K
Volume38.24K
52 Week high
$17.49
52 Week high$17.49
52 Week low
$4.15
52 Week low$4.15

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.